Glenmark Pharmaceuticals Limited is a global pharmaceutical company that operates in the areas of child health, dermatology, respiratory, oncology, cardiovascular, and diabetes, and offers a range of products and strong brands. Glenmark also has a sales force training program and a pipeline of Biologics and Small Molecules targeting hematological cancers and solid tumors. The company is dedicated to the manufacturing of sterile injectable products.
Basic Information
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
45.44%
Purchase this report to view the information.
36.18%
Purchase this report to view the information.
6.2%
Purchase this report to view the information.
3.52%
Purchase this report to view the information.
2.07%
Subsidiaries
Glenmark Dominicana SRL
100%
Glenmark Holdings SA (Switzerland)
100%
Company Performance
Financial values in the chart are available after Glenmark Pharmaceuticals Ltd. report is purchased.
Looking for more than just a company report?
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
36.83%▲
Total operating revenue
41.33%▲
Operating profit (EBIT)
16.1%▲
Net Profit (Loss) for the Period
-5.37%▼
Operating Profit Margin (ROS)
-2.34%▼
Net Profit Margin
-3.24%▼
Return on Equity (ROE)
-1.37%▼
Debt to Equity Ratio
-8.31%▼
